Geert-Jan Boons

This inventor holds 26 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Glycobiology Research. Top assignees: University of Georgia Research Foundation Inc, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Medimmune Limited. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geert-Jan Boons. Retrieved from https://idiyas.com/inventor/geert-jan-boons

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 10)

% Patents Active = 69.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 97(Granted Patents)

Company Filing History:

26 out of 870

University of Georgia Research Foundation Inc

patents

2 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugates

Oligosaccharide Standards

Glycopeptide

Chemical Synthesis

Chemo-Enzymatic Synthesis

Glycoconjugates

Synthetic Lipid A

Cyclopropenones

Alkynes

Feedback Prodrug

Liposome-Mediated Ligation

Heparan Sulfate

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503506 - Dual drug antibody-drug conjugates (2025-12-23),

2. 12152053 - Oligosaccharide analytical standards (2024-11-26),

3. 11872215 - Site-specific antibody-drug glyconjugates and methods (2024-01-16),

4. 11780872 - Oligosaccharide analytical standards (2023-10-10),

5. 10905678 - Site-specific antibody-drug glycoconjugates and methods (2021-02-02),

6. 10870710 - Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof (2020-12-22),

7. 10174132 - Heparan sulfate synthesis (2019-01-08),

8. 9938312 - Compounds and methods for chemical and chemo-enzymatic synthesis of complex glycans (2018-04-10),

9. 9932297 - Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds (2018-04-03),

10. 9725405 - Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds (2017-08-08),

11. 9446144 - Glycopeptide and uses thereof (2016-09-20),

12. 9315468 - Methods including latent 1,3-dipole-functional compounds and materials prepared thereby (2016-04-19),

13. 9310366 - Anthrax carbohydrates, synthesis and uses thereof (2016-04-12),

14. 9309276 - Synthetic lipid A derivative (2016-04-12),

15. 9227943 - Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds (2016-01-05),

Title: Innovations and Contributions of Geert-Jan Boons in Glycobiology

Introduction

Geert-Jan Boons, based in Athens, GA, is a prominent inventor known for his significant contributions to glycobiology. With a remarkable portfolio of 25 patents, he has continually pushed the boundaries of research and innovation, particularly in the realm of oligosaccharide analytical standards and antibody-drug conjugates.

Latest Patents

Among his latest inventions are two noteworthy patents. The first, titled "Oligosaccharide Analytical Standards," describes oligosaccharides and intermediates that are crucial for producing analytical standards. These compounds are instrumental for preparing more complex oligosaccharide and N-glycan products while allowing for high purity through selective stop/go synthetic methods.

The second patent, "Site-Specific Antibody-Drug Glyconjugates and Methods," presents groundbreaking methods for covalently linking antibodies or antibody fragments to cargo molecules, which can include therapeutic or diagnostic agents. This patented method employs enzymatic glycan remodeling combined with click chemistry to achieve selective and efficient post-translational attachment of cargo molecules to antibodies, further enhancing their therapeutic capabilities.

Career Highlights

Geert-Jan Boons has had a distinguished career characterized by his work with the University of Georgia Research Foundation and the United States Department of Health and Human Services, particularly with the Centers for Disease Control and Prevention. His innovative research has not only advanced scientific knowledge but has also fostered important applications in healthcare and diagnostics.

Collaborations

Throughout his career, Boons has collaborated with notable scientists such as Margaretha Wolfert and Jun Guo. These partnerships highlight the collaborative nature of scientific research, where interdisciplinary efforts can lead to significant advancements in the field.

Conclusion

Geert-Jan Boons exemplifies the spirit of innovation through his extensive patent portfolio and impactful research. His work in oligosaccharide chemistry and antibody-drug conjugates underscores the vital role of inventors in translating scientific discoveries into practical applications that benefit society.

Profile summary based on public USPTO records.